- Oops!Something went wrong.Please try again later.
Achiko AG / Key word(s): Capital Increase
Achiko AG Completes Capital Increase
Zurich, 30 October 2020 - Achiko AG (SWX:ACHI, ISIN CH0522213468) announces that following the financing round communicated on the 29th July 2020, its share capital recorded in the commercial register has been increased by 13,165,476 shares to 102,797,618 shares. The new shares have been issued out of the existing authorized capital and will be used towards settling existing commitments and to support the updated strategy of the company.
Through innovations in technology along with the company's unique operating footprint from Europe to Asia, Achiko seeks to transform markets and bring exceptional value to its customers, people, and shareholders. Achiko supports innovations in healthcare through its Teman Sehat ("Health Buddy") ecosystem and a novel saliva based Covid-19 testing technology, codenamed "Gumnuts", being developed with Regenacellx.sl.
Investor Relations & Press Contacts:
Press Contact Switzerland
End of ad hoc announcement
SIX Swiss Exchange
EQS News ID:
End of Announcement
EQS Group News Service